IP Library Granted Patent US 9,750,438
Granted Patent B2
US 9,750,438 · App. 14/015,831 · Granted Sep 5, 2017

CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction of insulin delivery

Inventors: Boris P. Kovatchev (Charlottesville, VA); Marc D. Breton (Charlottesville, VA); Stephen D. Patek (Charlottesville, VA)
Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
A61B5/14532A61B5/0004A61B5/4839A61B5/7275A61B5/746A61M5/1723G06F19/3437G06F19/3456G06F19/3468G06F19/3418
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,750,438
App. No.
14/015,831
Granted
Sep 5, 2017
Kind
B2
Abstract

An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises, but not limited thereto, a method and system (and related computer program product) for continually assessing the risk of hypoglycemia for a patient and then determining what action to take based on that risk assessment. A further embodiment results in two outputs: (1) an attenuation factor to be applied to the insulin rate command sent to the pump (either via conventional therapy or via open or closed loop control) and/or (2) a red/yellow/green light hypoglycemia alarm providing to the patient an indication of the risk of hypoglycemia. The two outputs of the CPHS can be used in combination or individually.

Claims (29)

1. A computer-implemented method for preventing or mitigating hypoglycemia in a patient, comprising:

receiving by a processor continuous metabolic measurements associated with the subject from a metabolic measurement device continuously making direct metabolic measurements;

continuously assessing by a processor a risk of hypoglycemia based on the received metabolic measurements;

evaluating by a processor risk of hypoglycemia based on the assessed risk of hypoglycemia; and

outputting to an output device a result of said evaluation, selected from one of:

a) no action being needed;

b) attenuation of insulin delivery being needed;

c) additional patient intervention being needed; and

d) attenuation of insulin delivery and additional patient intervention being needed.

2. A computer-implemented method for preventing or mitigating hypoglycemia in a subject, comprising:

receiving by a processor continuous metabolic measurements associated with the subject from a metabolic measurement device continuously making direct metabolic measurements;

assessing by a processor a risk of hypoglycemia based on the received metabolic measurements;

evaluating by a processor the risk of hypoglycemia based on the assessed risk of hypoglycemia; and

outputting an alarm when the risk of hypoglycemia exceeds a predetermined threshold.

3. A computer-implemented method for preventing or mitigating hypoglycemia in a subject, comprising:

receiving continuous metabolic measurements associated with the subject from a metabolic measurement device continuously making direct metabolic measurements;

assessing a risk of hypoglycemia based on the received metabolic measurements;

evaluating the risk of hypoglycemia based on the assessed risk of hypoglycemia;

providing a shut-down signal to an insulin pump to cease delivery of insulin to said subject for a predetermined time, upon evaluation of risk of hypoglycemia exceeding a predetermined threshold;

outputting an alarm alerting the subject that risk of hypoglycemia exceeds said predetermined threshold; and

enabling the subject to override said shut-down signal and continue delivery of insulin to said subject from said insulin pump.

4. A computer-implemented method for preventing or mitigating hypoglycemia in a subject, comprising:

receiving, by a processor, metabolic measurements associated with the subject from a metabolic measurement device continuously making direct metabolic measurements;

assessing, by a processor, a risk of hypoglycemia based on the received metabolic measurements; and

outputting to an output device a result of said evaluation, wherein the result is one of:

a) no action being needed;

b) attenuation of insulin being needed;

c) subject intervention being needed; and

d) attenuation of insulin and subject intervention being needed.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2017
From: KOVATCHEV, BORIS P; BRETON, MARC D; PATEK, STEPHEN D
To: UNIVERSITY OF VIRGINIA
Reel/Frame 043903/0906 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2017
From: UNIVERSITY OF VIRGINIA
To: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
Reel/Frame 043904/0097 →
Continuity (5)
Continuation 13203469
Provisional Application 61155357 · Feb 25, 2009
Provisional Application 61182485 · May 29, 2009
Provisional Application 61263932 · Nov 24, 2009
Related Publication 20140046159A1 · Feb 13, 2014